ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER CELLS PLUS RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA

被引：41

|

作者：

ONISHI, S

SAIBARA, T

FUJIKAWA, M

SAKAEDA, H

MATSUURA, Y

MATSUNAGA, Y

YAMAMOTO, Y

机构：

来源：

HEPATOLOGY | 1989年 / 10卷 / 03期

关键词：

D O I：

10.1002/hep.1840100318

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：349 / 353

页数：5

相关论文

共 50 条

[11] ADOPTIVE IMMUNOTHERAPY OF A RAT GLIOMA USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2
TZENG, JJ
BARTH, RF
CLENDENON, NR
GORDON, WA
CANCER RESEARCH, 1990, 50 (14) : 4338 - 4343
[12] ADMINISTRATION OF SLOWLY RELEASED RECOMBINANT INTERLEUKIN-2 - AUGMENTATION OF THE EFFICACY OF ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
NISHIMURA, T
UCHIYAMA, Y
YAGI, H
HASHIMOTO, Y
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 91 (01) : 21 - 27
[13] ADOPTIVE IMMUNOTHERAPY OF HUMAN CANCER USING LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
SCHOOF, DD
GRAMOLINI, BA
DAVIDSON, DL
MASSARO, AF
WILSON, RE
EBERLEIN, TJ
CANCER RESEARCH, 1988, 48 (17) : 5007 - 5010
[14] THE ADOPTIVE IMMUNOTHERAPY OF CANCER USING LYMPHOKINE ACTIVATED KILLER-CELLS AND RECOMBINANT INTERLEUKIN-2
ETTINGHAUSEN, SE
ROSENBERG, SA
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1986, 9 (01): : 51 - 71
[15] LYMPHOKINE-ACTIVATED KILLER-CELL AND INTERLEUKIN-2 INHIBITORS - THEIR ROLE IN ADOPTIVE IMMUNOTHERAPY
EGGERMONT, AMM
SUGARBAKER, PH
CELLULAR IMMUNOLOGY, 1987, 107 (02) : 384 - 394
[16] A NEW MEANS OF TREATING METASTATIC MELANOMA - ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER CELLS AND INTERLEUKIN-2
KEILHOLZ, U
WELTERS, H
DUMMER, R
TILGEN, W
HUNSTEIN, W
HAUTARZT, 1988, 39 (06): : 378 - 381
[17] ADJUVANT CHEMOIMMUNOTHERAPY FOR HEPATOCELLULAR-CARCINOMA PATIENTS - ADRIAMYCIN, INTERLEUKIN-2, AND LYMPHOKINE-ACTIVATED KILLER-CELLS VERSUS ADRIAMYCIN ALONE
KAWATA, A
UNE, Y
HOSOKAWA, M
WAKIZAKA, Y
NAMIENO, T
UCHINO, J
KOBAYASHI, H
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (03): : 257 - 262
[18] HEMATOLOGIC EFFECTS OF IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER-CELLS AND RECOMBINANT INTERLEUKIN-2 IN CANCER-PATIENTS
ETTINGHAUSEN, SE
MOORE, JG
WHITE, DE
PLATANIAS, L
YOUNG, NS
ROSENBERG, SA
BLOOD, 1987, 69 (06) : 1654 - 1660
[19] INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN THE TREATMENT OF CHILDHOOD PRIMARY HEPATOCELLULAR-CARCINOMA - A PRELIMINARY-REPORT
HSIEH, KH
CHANG, JS
WU, HL
CHU, CT
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 1987, 5 (01): : 13 - 16
[20] ADOPTIVE CELLULAR THERAPY WITH LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS PLUS INTERLEUKIN-2 (IL-2)
LONGO, DL
INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 97 - 97

← 1 2 3 4 5 →